Implanon status report: not on U.S. market yet.
D000569:Americas; D002986:Clinical Trials as Topic; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017135:Desogestrel; D019049:Developed Countries; D004467:Economics; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007878:Legislation as Topic; D008389:Marketing of Health Services; D009656:North America; D012106:Research; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017135:Desogestrel
Americas; Clinical Research; Clinical Trials; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants--beneficial effects; Contraceptive Methods--beneficial effects; Desogestrel; Developed Countries; Economic Factors; Evaluation; Evaluation Report; Family Planning; Legislation; Marketing; North America; Northern America; Product Approval; Research Methodology; United States